Several studies have found that impaired ISG expression in lymphocytes of certain malignancies, including melanoma, breast, and gastrointestinal cancers, led to defects in IFN signaling in lymphocytes, suggesting a common cancer-associated mechanism of immune dysfunction [25]. This evidence concerns the gene IFNA1 and cancer.